Carbon Ion Boost for Advanced Lung Cancer
Part of Cancer, Lungs & breathing clinical trials.
This trial tests a new way to give radiation therapy (carbon ion boost) to people with advanced, inoperable lung cancer. The goal is to see if targeting the most aggressive parts of the tumor with a higher dose can improve outcomes.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be between 18 and 80 years old.
- You must have stage III non-small cell lung cancer (NSCLC) that is locally advanced and cannot be removed with surgery.
- Your primary tumor must be at least 4 cm in size before the radiation treatment.
- You must be generally able to care for yourself (ECOG score 0–2).
- Your blood counts, lung function, heart function, liver, and kidney function must be within certain safe limits.
- You cannot have had radiation to your chest before, or have certain metal implants or a pacemaker.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether carbon ion radiation (high-energy targeted radiation) can control peripheral non-small cell lung cancer in people who are medically unable to have surgery. It may help shrink or stop tumor growth while limiting harm to nearby organs.
This trial tests carbon ion radiotherapy for adults 75 and older with locally advanced non-small cell lung cancer who cannot have surgery. The goal is to see if this precise type of radiation can treat the cancer effectively with fewer side effects.
This trial tests whether a special type of focused radiation therapy can effectively treat advanced non-small cell lung cancer (the most common type) as an upfront treatment. It may help patients avoid or delay chemotherapy while controlling their cancer.
This trial tests whether adding a NAD+ booster (NMN) to radiation and immunotherapy can help people with advanced lung cancer. It may improve the effectiveness of the treatment and help you live longer.
This study tests whether adding focused radiation therapy to immunotherapy can help patients with advanced non-small cell lung cancer whose cancer has progressed despite prior immunotherapy. The goal is to see if this combination works better than immunotherapy alone.
This trial combines chemotherapy, immunotherapy, and a special type of radiation called carbon ion therapy to treat lung cancer that has not spread but cannot be removed with surgery. The goal is to see if this combination can shrink the tumor and improve outcomes.
Hear when a new Non Small Cell Lung Cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.